
Paul Steven Yamauchi MD PhD
Cosmetic Dermatology, Dermatologic Surgery
Medical Director Dermatology Institute and Skin Care Center Medical Director Clinical Science Institute Clinical Assistant Professor David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Center
Join to view full profile
2730 Wilshire BlvdSte 650Santa Monica, CA 90403
Phone+1 310-829-4104
Fax+1 310-829-4150
Dr. Yamauchi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Yamauchi is a dermatologist in private practice and medical director at both the Dermatology Institute & Skin Care Center and Clinical Science Institute in Santa Monica, California. Dr. Yamauchi is a clinical assistant professor of medicine in the Division of Dermatology at the David Geffen School of Medicine at UCLA.
Dr. Yamauchi earned his BS in biochemistry at the University of California at Los Angeles, his PhD in biologic chemistry at the University of California at Santa Barbara, and his MD at Case Western Reserve University School of Medicine in Cleveland. He completed his residency in dermatology at UCLA School of Medicine and a cosmetic surgery fellowship affiliated with UCLA School of Medicine.
Dr. Yamauchi is a fellow with the American Academy of Dermatology, the American Society of Dermatology Surgery, California Dermatology Society, and the Los Angeles Metropolitan Dermatologic Society. He serves on the editorial board of various journals and on several task force committees for the American Academy of Dermatology. He is the author or co-author of more than 120 peer-reviewed publications, including several books. Dr. Yamauchi has edited a book entitled “Biologic and Systemic Agents in Dermatology”.
Dr. Yamauchi has conducted over 200 clinical research trials as a principal investigator at the Clinical Science Institute in Santa Monica and is recognized as a key opinion leader in psoriasis, atopic dermatitis, hidradenitis suppurativa, vitiligo, alopecia areata and other inflammatory skin disorders. He has previously served on the Medical Board for the National Psoriasis Foundation and on the Scientific Advisory Council for the National Eczema Association.
Dr. Yamauchi has been the recipient of many top awards including the Castle Connolly’s listing of American’s Top Doctors, Newsweek Magazine Best Medical Dermatologists, the Marquis Who’s Who in Medicine and Healthcare, Super Doctors in Southern California, and the Expert Network.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Dermatology, 1997 - 2000
University of Rochester Medical CenterResidency, Orthopaedic Surgery, 1992 - 1994
University of Rochester Medical CenterInternship, Transitional Year, 1991 - 1992
Case Western Reserve University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1994 - 2028
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2013, 2015-2016
- CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2013, 2015-2016
- Marquis Who's Who in America
Clinical Trials
- Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
- A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
- Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Publications & Presentations
PubMed
- 1 citationsComparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis.Paul S Yamauchi, Vincent Chow, Daniel T Mytych, Muhan Zhou, Waldemar Radziszewski
Advances in Therapy. 2026-06-01 - 1 citationsResults from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis.Joseph F Merola, Lyn Guenther, Charles Lynde, Kim A Papp, Lawrence Charles Parish
Journal of the European Academy of Dermatology and Venereology. 2026-02-01 - Impact of Oral DFD-29, a Low-Dose Formulation of Minocycline, on Quality of Life in Patients with Rosacea: Results of Two Phase 3 Randomized Controlled Trials.Linda Stein Gold, Paul Yamauchi, Thomas Dirschka, Athanasios Tsianakas, Sunil Dhawan
The Journal of Clinical and Aesthetic Dermatology. 2025-10-01
Authored Content
- Big Advances for PsoriasisMay 2021
Press Mentions
Impact of Oral DFD-29, a Low-Dose Formulation of Minocycline, on Quality of Life in Patients with Rosacea: Results of Two Phase 3 Randomized Controlled TrialsNovember 3rd, 2025
Sixty Years of Benzoyl Peroxide Use in DermatologyJanuary 1st, 2023
Intralesional Mode of Drug Administration in PsoriasisJanuary 26th, 2022
Committees
- Member, Medical Board National Psoriasis Foundation
- Committee Member, American Academy of Dermatology Task Force for Poster Sessions
Research History
- Principle Investigator- Psoriasis - Atopic Dermatitis - Acne - Rosacea - Actinic Keratosis - Hyperhidrosis - Cosmetic dermatology
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: